FDA News & Updates
This section provides a brief overview of new cancer drugs and new indications
approved by the FDA between February 28 and March 31, 2022. Read More ›
This section provides a brief overview of new cancer drugs and new
fast-track designations approved by the FDA between
January 10, 2022, and January 25, 2022. Read More ›
This section provides a brief overview of new cancer drugs and indications approved by the FDA between November 29, 2021, and December 15, 2021. Read More ›
This section provides a brief overview of new cancer drugs and indications approved by the FDA between August 13, 2021, and September 22, 2021. Read More ›
On September 20, 2021, the FDA announced the availability of its revised final guidance for industry on biosimilar development and the Biologics Price Competition and Innovation Act of 2009 (BPCI Act). Read More ›
This section provides a brief overview of new cancer drugs and new indications
approved by the FDA between June 30, 2021, and July 26, 2021. Read More ›
This section provides a brief overview of new cancer drugs and new indications approved by the FDA between May 5, 2021, and May 28, 2021. Read More ›
This section provides a brief overview of new cancer drugs and new indications approved by the FDA between April 13, 2021, and April 23, 2021. Read More ›
This section provides a brief overview of new cancer drugs and indications approved by the FDA between February 5, 2021, and February 22, 2021. Read More ›
This section provides a brief overview of new cancer drugs approved by the FDA between November 25, 2020, and December 18, 2020. Read More ›